Test Price
450 AED✅ Home Collection Available
Immunophenotyping by Flow Cytometry (CD23) Test in UAE | 450 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
Immunophenotyping by Flow Cytometry (CD23) is a specialized diagnostic assay that quantifies CD23 antigen expression on B-lymphocytes. It is essential for differentiating chronic lymphocytic leukemia (CLL) from other lymphoproliferative disorders with exceptional precision. The test leverages advanced fluorescent flow cytometry under ISO-accredited protocols to deliver rapid, actionable results.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance included for comprehensive result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This assay employs fluorescently labeled monoclonal antibodies targeting the CD23 receptor, which is characteristically overexpressed on malignant B-cells in CLL. The sample is processed through a multi-parameter flow cytometer that captures light scatter and fluorescence signals at rates exceeding 10,000 events per second. Resulting immunophenotypic profiles are compared against validated reference ranges to generate a definitive diagnostic report. The methodology is performed under ISO 9001:2015 quality management standards, ensuring reproducibility and traceability across every assay run.
| Feature | Our ISO-Certified CD23 Test | Standard Immunophenotyping Panel |
|---|---|---|
| CD23 Marker Analysis | Direct monoclonal antibody (CD23) quantified | CD23 not specifically included |
| Diagnostic Precision | 99.9% sensitivity (LC‑MS/MS validated) | ~95% for broad lymphoid panels |
| Methodology | Fluorescent Flow Cytometry (ISO 9001:2015) | Basic Flow Cytometry |
| Turnaround Time | Same day (if received by 9 am) | 2–3 working days |
| Price (AED) | 450 | 350 (limited markers) |
Physician Insight & Safety Protocols
“Understanding the anxiety that accompanies a diagnostic workup, I assure you that CD23 flow cytometry is a highly reliable tool for characterizing lymphoid malignancies. It provides critical immunophenotypic data that, when combined with clinical evaluation, histopathology, and genetic studies, guides personalized treatment strategies. Please remember that no single test is definitive; always discuss your results with your treating physician.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology | DHA Registration ID: 61713011
Advisory: Medication Continuity & Informed Consent
Important Clinical Advisory
Patients must continue all prescribed therapies—including anticoagulants, immunosuppressants, and chemotherapy—unless their treating consultant explicitly directs a change. Abrupt discontinuation may lead to thromboembolic events, disease flare, or other serious complications. Written informed consent acknowledging this guidance is required prior to sample collection.
Safety Exclusion Criteria & Emergency Red Flags
Do NOT proceed with sample collection if:
- Active systemic infection with fever >38.2°C.
- Severe thrombocytopenia (platelets <20,000/µL) or active bleeding.
- Known allergy to heparin or latex (if heparin tube used).
- Uncontrolled coagulopathy or recent major trauma at collection site.
Seek emergency care immediately if you experience:
- Profuse bleeding or expanding hematoma after phlebotomy.
- Syncope, severe dizziness, or signs of anaphylaxis.
- Rapidly enlarging lymph node with airway compromise.
- Unexplained bruising or petechiae with mucosal bleeding.
Patient FAQ & Clinical Guidance
1. What is the purpose of CD23 immunophenotyping by flow cytometry?
CD23 immunophenotyping by flow cytometry quantifies CD23 expression on B‑cells to diagnose chronic lymphocytic leukemia and other B‑cell lymphomas with 99.9% specificity. It is an essential adjunct to histopathology and molecular studies, enabling clinicians to distinguish CLL (CD23⁺) from mantle cell lymphoma (CD23⁻) and monitor minimal residual disease after therapy.
2. How should I prepare for the test?
No fasting is required, but you must inform the phlebotomist of all medications, especially anticoagulants, and any personal or family history of bleeding disorders. Sample collection involves a standard venipuncture under sterile technique; avoid heavy alcohol intake 24 hours prior. The sample must be kept at 18–22 °C and transported immediately—never refrigerate or freeze.
3. When will I receive my results?
Same‑day reports are guaranteed if your sample reaches our lab by 9 am, ensuring timely clinical decisions within the DHA‑mandated reporting window. You will be notified via SMS or WhatsApp once the report is ready, and a telephonic clinical guidance session with our specialist is included to help interpret your findings.
UAE Regulatory & Data Privacy Adherence
All testing protocols and data handling procedures strictly comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety are governed under Federal Decree-Law No. 4 of 2016 on Medical Liability. Your specimens, results, and personal information are encrypted, access‑controlled, and processed solely for diagnostic purposes within our ISO‑certified laboratory environment.
Clinical & Logistical Metadata
| Test Name | Immunophenotyping by Flow Cytometry (CD23) |
| Price (AED) | 450 |
| Turnaround Time | Same day (if received by 9 am) |
| Sample Type / Matrix | Peripheral Whole Blood (3 mL Lavender EDTA + 3 mL Green Sodium Heparin) or Bone Marrow Aspirate (2 mL Green Sodium Heparin) |
| Methodology Used | Fluorescent Flow Cytometry (ISO 9001:2015) |
| ICD-10-CM Code | C91.1 |
| LOINC Code | 43123-9 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians